Literature DB >> 31246479

Low-Frequency Raman Spectroscopic Study on Compression-Induced Destabilization in Melt-Quenched Amorphous Celecoxib.

Ka Rlis Be Rziņš1, Sara J Fraser-Miller1, Thomas Rades2,3, Keith C Gordon1.   

Abstract

A series of melt-quenched disks of amorphous celecoxib were obtained using two different cooling rates (>100 °C/min and ∼25-30 °C/min) and subjected to different compression pressures (125, 250, and 500 MPa) and dwell times (0, 30, and 60 s). The kinetics of crystallization for these differently prepared melt-quenched disks were probed using a number of methods. Low-frequency Raman spectroscopy was used to monitor isothermal crystallization kinetics, whereas dynamic differential scanning calorimetry served as a complimentary technique to identify changes in form. Although both compression parameters destabilized the amorphous celecoxib, the dwell time was found to have a more critical overall effect. Additionally, the sample history was affirmed to be a factor for limiting the magnitude of compression-induced destabilization.

Entities:  

Keywords:  amorphous drugs; celecoxib; compression-induced destabilization; differential scanning calorimetry; low-frequency Raman spectroscopy

Mesh:

Substances:

Year:  2019        PMID: 31246479     DOI: 10.1021/acs.molpharmaceut.9b00557

Source DB:  PubMed          Journal:  Mol Pharm        ISSN: 1543-8384            Impact factor:   4.939


  2 in total

1.  Explanation for the selective crystallization from inosine solutions using mid-frequency Raman difference spectra analysis.

Authors:  Fenghua Chen; Chenmei Yang; Xinyu Cheng; Yingjie Fan; Xinyuan Chen; Shizhao Ren; Rongrong Xue
Journal:  RSC Adv       Date:  2022-06-22       Impact factor: 4.036

2.  Low- versus Mid-frequency Raman Spectroscopy for in Situ Analysis of Crystallization in Slurries.

Authors:  Jaana Koskela; Joshua J Sutton; Tiina Lipiäinen; Keith C Gordon; Clare J Strachan; Sara J Fraser-Miller
Journal:  Mol Pharm       Date:  2022-05-03       Impact factor: 5.364

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.